CancerResource--updated database of cancer-relevant proteins, mutations and interacting drugs

Area of Science:

• Bioinformatics
• Genomics
• Pharmacology

Background:

• The growing need for personalized cancer therapy necessitates systems integrating drug-target interactions, gene expression, and mutation data.
• Existing knowledge bases require enhanced connections for a comprehensive overview of drug-target relationships and supporting evidence.

Purpose of the Study:

• To present an updated version of CancerResource, a freely accessible database for cancer drug discovery and personalized medicine.
• To establish novel information connections for a better overview of drug-target data and supporting analyses.

Main Methods:

• The CancerResource database was updated with approximately 91,000 drug-target relations, over 2,000 cancer cell lines, and drug sensitivity data for 50,000 drugs.
• Implemented capabilities for uploading and comparing external gene expression and mutation data against the database's cell lines.
• Integrated target genes and compounds onto cancer-related pathways and developed cellular fingerprints (mutations, expression, drug sensitivity).

Main Results:

• The updated CancerResource provides extensive data on drug-target interactions, cancer cell lines, and drug sensitivity.
• The system allows for direct comparison of patient-derived expression and mutation data with curated cell line data.
• Pathway analysis and cellular fingerprinting facilitate understanding of genotype-drug sensitivity associations.

Conclusions:

• CancerResource serves as a valuable resource for researchers and clinicians in cancer drug discovery and personalized therapy.
• The database facilitates the identification of optimal drug treatments by matching patient tumor profiles to the most similar cell line profiles.
• Enhanced data integration and analysis tools in CancerResource support informed decisions for individual cancer treatment strategies.